[ad_1]
The EU remembers AstraZeneca The EU also wants to see clearly about delays and cuts and has convened AstraZeneca this Monday, pointing out two objectives: to have a clear schedule that allows to plan deliveries and to speed up distribution.
Vaccination centers: missing precision syringes But the government also has to grapple with two other issues on the table: the alarm coming from several regional vaccination centers, including Lombardy, Sicily and Emilia Romagna, about the lack of precision syringes, and the need to prevent variants of Covid. , from the English to the South African that worries much more, cause infections to explode also in Italy as has already happened in several European countries.
Commissioner Arcuri denies it: it is false In the first point comes Arcuri’s refusal: “It is false”, fewer syringes were distributed “for the trivial reason that Pfizer sent us fewer vials of vaccine.”
Variations, Rezza: raising the measures On the other hand, on the risk of variants, the issue is more complex, so much so that the executive, according to the director of Prevention of the Ministry of Health, Gianni Rezza, is evaluating the possibility of “raising the measures.”
The vaccine plan, permanent government-Regions coordination The government, with the Minister of Regional Affairs Francesco Boccia, convened the Regions together with Speranza and Arcuri to update the vaccine plan presented by the Minister of Health to Parliament on December 2. The first doses of Astrazeneca, if the EMA gives the green light to the vaccine, will arrive on February 15, then again on March 28 and 15. According to the initial plan, 28 million and 269 thousand doses should have arrived in Italy in the first quarter of 2021. An amount that is now evident to all will not be respected: by the end of March the available doses will be less than 15 million, for therefore about half of what is expected. Astrazeneca has effectively confirmed the reduction due to a production problem, a cut of 60% that, explained both Conte and Arcuri, for Italy would mean going from 8 million to 3.4 million doses. To which should be added the 8.7 million from Pfizer (if the US company returns to initial supplies) and the 1.3 million from Moderna.
Zaia: turning to Russian and Chinese vaccines A situation that led the governor of Veneto Zaia, present at the meeting, to suggest that “if there is a green light from Ema for Russian or Chinese vaccines, this solution can also be used.” It is, therefore, a question of reviewing the objectives, as confirmed by the president of the Superior Council of Health Franco Locatelli: “the reduction of the productive capacity of AstraZeneca will require the remodeling of the campaign”.
Fight between Commissioner Arcuri and President De Luca The meeting between the Regions and the government was marked by the heated dispute between the emergency commissioner and the president of Campania. Vincenzo De Luca reiterated what he had already said on Friday during the usual Facebook direct, that is, that there would be an “inequality” with respect to the distribution of vaccines provided for by the national plan in Campania. De Luca reiterated that the distribution must be made according to the number of inhabitants of the Region, which has not yet happened. Consideration that annoyed Domenico Arcuri, who would get angry when answering harshly. Therefore, Arcuri has returned the allegations to the sender, even if it appears that the tones, in any case, “remained civilized”.
In March, 7 million Italians will be vaccinated It should be possible to achieve the priority commitment, vaccinating all health and social health workers, guests and staff of the Rsa, over 80 and fragile patients, oncology, cardiology and hematology by March. In total, almost 7 million Italians. But not the other categories: the 13 million and 400 thousand Italians between 60 and 79 years old, the 7 million and 400 thousand with at least one chronic comorbidity, in addition to essential services personnel: teachers and school personnel, police forces. , prison staff and inmates.
Age Restrictions for AstraZeneca Vaccine There is also another element to consider. When the EMA gives the green light to the AstraZeneca vaccine, Locatelli emphasizes, it will be necessary to see “what type of approval will be given”, that is, if it will be “conditioned to certain age parameters rather than the percentage of vaccination coverage.” . Basically, if the vaccine appears to be recommended for the population under 55 years of age, Italy will have to identify new criteria to define priority categories, giving priority to the youngest.
[ad_2]
